Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

Understanding and addressing social determinants to advance cancer health equity in the United States: A blueprint for practice, research, and policy.

Alcaraz KI, Wiedt TL, Daniels EC, Yabroff KR, Guerra CE, Wender RC.

CA Cancer J Clin. 2019 Oct 29. doi: 10.3322/caac.21586. [Epub ahead of print]

2.

Should we stop investing in chemoprevention trials in oncology?

Weller D, Wender RC.

Lancet Oncol. 2019 Jun;20(6):766-767. doi: 10.1016/S1470-2045(19)30302-X. No abstract available.

PMID:
31162091
3.

The American Cancer Society 2035 challenge goal on cancer mortality reduction.

Ma J, Jemal A, Fedewa SA, Islami F, Lichtenfeld JL, Wender RC, Cullen KJ, Brawley OW.

CA Cancer J Clin. 2019 Sep;69(5):351-362. doi: 10.3322/caac.21564. Epub 2019 May 8.

4.

Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening.

Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC.

CA Cancer J Clin. 2019 May;69(3):184-210. doi: 10.3322/caac.21557. Epub 2019 Mar 15.

5.

Minimizing the burden of cancer in the United States: Goals for a high-performing health care system.

Yabroff KR, Gansler T, Wender RC, Cullen KJ, Brawley OW.

CA Cancer J Clin. 2019 May;69(3):166-183. doi: 10.3322/caac.21556. Epub 2019 Feb 20.

6.

A blueprint for cancer screening and early detection: Advancing screening's contribution to cancer control.

Wender RC, Brawley OW, Fedewa SA, Gansler T, Smith RA.

CA Cancer J Clin. 2019 Jan;69(1):50-79. doi: 10.3322/caac.21550. Epub 2018 Nov 19.

7.

Creating and Implementing a National Public Health Campaign: The American Cancer Society's and National Colorectal Cancer Roundtable's 80% by 2018 Initiative.

Wender RC, Doroshenk M, Brooks D, Hotz J, Smith RA.

Am J Gastroenterol. 2018 Dec;113(12):1739-1741. doi: 10.1038/s41395-018-0384-1. Epub 2018 Nov 9. No abstract available.

8.

Equitably improving outcomes for cancer survivors and supporting caregivers: A blueprint for care delivery, research, education, and policy.

Alfano CM, Leach CR, Smith TG, Miller KD, Alcaraz KI, Cannady RS, Wender RC, Brawley OW.

CA Cancer J Clin. 2019 Jan;69(1):35-49. doi: 10.3322/caac.21548. Epub 2018 Oct 30.

9.

Toward the control of cancer.

Brawley OW, Gansler T, Wender RC.

CA Cancer J Clin. 2018 Sep;68(5):327-328. doi: 10.3322/caac.21461. Epub 2018 Jul 10. No abstract available.

10.

A blueprint for the primary prevention of cancer: Targeting established, modifiable risk factors.

Gapstur SM, Drope JM, Jacobs EJ, Teras LR, McCullough ML, Douglas CE, Patel AV, Wender RC, Brawley OW.

CA Cancer J Clin. 2018 Nov;68(6):446-470. doi: 10.3322/caac.21496. Epub 2018 Oct 10. Erratum in: CA Cancer J Clin. 2019 Mar;69(2):158.

11.

An assessment of progress in cancer control.

Siegel RL, Jemal A, Wender RC, Gansler T, Ma J, Brawley OW.

CA Cancer J Clin. 2018 Sep;68(5):329-339. doi: 10.3322/caac.21460. Epub 2018 Jul 10.

12.

The American Cancer Society public health statement on eliminating combustible tobacco use in the United States.

Douglas CE, Henson R, Drope J, Wender RC.

CA Cancer J Clin. 2018 Jul;68(4):240-245. doi: 10.3322/caac.21455. Epub 2018 Jun 11. No abstract available.

13.

From guideline to practice: New shared decision-making tools for colorectal cancer screening from the American Cancer Society.

Volk RJ, Leal VB, Jacobs LE, Wolf AMD, Brooks DD, Wender RC, Smith RA.

CA Cancer J Clin. 2018 Jul;68(4):246-249. doi: 10.3322/caac.21459. Epub 2018 May 30. No abstract available.

14.

Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.

Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte SJ, Etzioni R, McKenna MT, Oeffinger KC, Shih YT, Walter LC, Andrews KS, Brawley OW, Brooks D, Fedewa SA, Manassaram-Baptiste D, Siegel RL, Wender RC, Smith RA.

CA Cancer J Clin. 2018 Jul;68(4):250-281. doi: 10.3322/caac.21457. Epub 2018 May 30.

15.

Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening.

Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Brawley OW, Wender RC.

CA Cancer J Clin. 2018 Jul;68(4):297-316. doi: 10.3322/caac.21446. Epub 2018 May 30. Review.

16.

Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States.

Fedewa SA, Gansler T, Smith R, Sauer AG, Wender R, Brawley OW, Jemal A.

Ann Fam Med. 2018 Mar;16(2):139-144. doi: 10.1370/afm.2200.

17.

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG.

J Clin Oncol. 2018 Feb 1;36(4):414-424. doi: 10.1200/JCO.2017.74.1173. Epub 2017 Dec 13. Review.

18.

Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening.

Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Brawley OW, Wender RC.

CA Cancer J Clin. 2017 Mar;67(2):100-121. doi: 10.3322/caac.21392. Epub 2017 Feb 7.

19.

Screening for Colorectal Cancer and Evolving Issues for Physicians and Patients: A Review.

Lieberman D, Ladabaum U, Cruz-Correa M, Ginsburg C, Inadomi JM, Kim LS, Giardiello FM, Wender RC.

JAMA. 2016 Nov 22;316(20):2135-2145. doi: 10.1001/jama.2016.17418. Review.

PMID:
27893135
20.

Propofol versus midazolam for premedication: a placebo‑controlled, randomized double‑blinded study.

Elvir Lazo OL, White PF, Tang J, Yumul R, Cao X, Yumul F, Hausman J, Hernandez Conte A, Anand KK, Hemaya EG, Zhang X, Wender RH.

Minerva Anestesiol. 2016 Nov;82(11):1170-1179. Epub 2016 Sep 9.

21.

Cancer Screening Navigation: From Promising Practice to Standard of Care.

Wender R.

JAMA Intern Med. 2016 Jul 1;176(7):937-8. doi: 10.1001/jamainternmed.2016.2295. No abstract available.

PMID:
27273140
22.

Comparison of three video laryngoscopy devices to direct laryngoscopy for intubating obese patients: a randomized controlled trial.

Yumul R, Elvir-Lazo OL, White PF, Sloninsky A, Kaplan M, Kariger R, Naruse R, Parker N, Pham C, Zhang X, Wender RH.

J Clin Anesth. 2016 Jun;31:71-7. doi: 10.1016/j.jclinane.2015.12.042. Epub 2016 Mar 23.

23.

Comparison of the C-MAC video laryngoscope to a flexible fiberoptic scope for intubation with cervical spine immobilization.

Yumul R, Elvir-Lazo OL, White PF, Durra O, Ternian A, Tamman R, Naruse R, Ebba H, Yusufali T, Wong R, Hernandez Conte A, Farnad S, Pham C, Wender RH.

J Clin Anesth. 2016 Jun;31:46-52. doi: 10.1016/j.jclinane.2015.12.045. Epub 2016 Mar 22.

24.

The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: Results and reflections.

Byers T, Wender RC, Jemal A, Baskies AM, Ward EE, Brawley OW.

CA Cancer J Clin. 2016 Sep;66(5):359-69. doi: 10.3322/caac.21348. Epub 2016 May 13.

25.

Clinical Breast Examination and Breast Cancer Screening Guideline--Reply.

Oeffinger KC, Fontham ET, Wender RC.

JAMA. 2016 Apr 5;315(13):1404. doi: 10.1001/jama.2016.0689. No abstract available.

PMID:
27046374
26.

Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening.

Smith RA, Andrews K, Brooks D, DeSantis CE, Fedewa SA, Lortet-Tieulent J, Manassaram-Baptiste D, Brawley OW, Wender RC.

CA Cancer J Clin. 2016 Mar-Apr;66(2):96-114. doi: 10.3322/caac.21336. Epub 2016 Jan 21. Review.

27.

The American Cancer Society's Approach to Addressing the Cancer Burden in the LGBT Community.

Wender R, Sharpe KB, Westmaas JL, Patel AV.

LGBT Health. 2016 Feb;3(1):15-18. Epub 2015 Nov 5.

PMID:
26789399
28.

Cancer screening, prevention, and treatment in people with mental illness.

Weinstein LC, Stefancic A, Cunningham AT, Hurley KE, Cabassa LJ, Wender RC.

CA Cancer J Clin. 2016 Mar-Apr;66(2):134-51. doi: 10.3322/caac.21334. Epub 2015 Dec 10.

29.

Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.

Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, Walter LC, Church TR, Flowers CR, LaMonte SJ, Wolf AM, DeSantis C, Lortet-Tieulent J, Andrews K, Manassaram-Baptiste D, Saslow D, Smith RA, Brawley OW, Wender R; American Cancer Society.

JAMA. 2015 Oct 20;314(15):1599-614. doi: 10.1001/jama.2015.12783. Erratum in: JAMA. 2016 Apr 5;315(13):1406.

30.

The expanding role of primary care in cancer control.

Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, Fahey T, Grassi L, Grunfeld E, Gupta S, Hamilton W, Hiom S, Hunter D, Lyratzopoulos G, Macleod U, Mason R, Mitchell G, Neal RD, Peake M, Roland M, Seifert B, Sisler J, Sussman J, Taplin S, Vedsted P, Voruganti T, Walter F, Wardle J, Watson E, Weller D, Wender R, Whelan J, Whitlock J, Wilkinson C, de Wit N, Zimmermann C.

Lancet Oncol. 2015 Sep;16(12):1231-72. doi: 10.1016/S1470-2045(15)00205-3. Review.

PMID:
26431866
31.

Population-based programs for increasing colorectal cancer screening in the United States.

Verma M, Sarfaty M, Brooks D, Wender RC.

CA Cancer J Clin. 2015 Nov-Dec;65(6):497-510. doi: 10.3322/caac.21295. Epub 2015 Sep 1. Review.

32.

How many individuals will need to be screened to increase colorectal cancer screening prevalence to 80% by 2018?

Fedewa SA, Ma J, Sauer AG, Siegel RL, Smith RA, Wender RC, Doroshenk MK, Brawley OW, Ward EM, Jemal A.

Cancer. 2015 Dec 1;121(23):4258-65. doi: 10.1002/cncr.29659. Epub 2015 Aug 26.

33.

Single-Gene Genotyping and Personalized Preventive Care--Reply.

Wender RC.

JAMA. 2015 Jul 21;314(3):298-9. doi: 10.1001/jama.2015.6236. No abstract available.

PMID:
26197194
34.

A letter from the National Colorectal Cancer Roundtable.

Wender RC.

Dig Dis Sci. 2015 Mar;60(3):594-5. No abstract available.

PMID:
25961080
35.

Aspirin and NSAID chemoprevention, gene-environment interactions, and risk of colorectal cancer.

Wender RC.

JAMA. 2015 Mar 17;313(11):1111-2. doi: 10.1001/jama.2015.1032. No abstract available.

PMID:
25781439
36.

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR.

Diabetologia. 2015 Mar;58(3):429-42. doi: 10.1007/s00125-014-3460-0. Epub 2015 Jan 13. No abstract available.

PMID:
25583541
37.

Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening.

Smith RA, Manassaram-Baptiste D, Brooks D, Doroshenk M, Fedewa S, Saslow D, Brawley OW, Wender R.

CA Cancer J Clin. 2015 Jan-Feb;65(1):30-54. doi: 10.3322/caac.21261. Epub 2015 Jan 8. Review.

38.

Perioperative factors associated with HCAHPS responses of 2,758 surgical patients.

Maher DP, Wong W, Woo P, Padilla C, Zhang X, Shamloo B, Rosner H, Wender R, Yumul R, Louy C.

Pain Med. 2015 Apr;16(4):791-801. doi: 10.1111/pme.12651. Epub 2014 Dec 28.

PMID:
25545695
39.

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR.

Diabetes Care. 2015 Jan;38(1):140-9. doi: 10.2337/dc14-2441. No abstract available.

PMID:
25538310
40.

Does small-dose fentanyl improve perioperative outcomes in the ambulatory setting? A randomized, double-blind, placebo-controlled study.

White PF, Elvir-Lazo OL, Zaentz AS, Kariger R, Yumul R, Khany MM, Stern A, Vuong M, Wender RH.

Acta Anaesthesiol Scand. 2015 Jan;59(1):56-64. doi: 10.1111/aas.12424. Epub 2014 Oct 20.

PMID:
25329822
41.

Evaluating a multipayer medical home intervention.

Valko G, Wender R.

JAMA. 2014 Jul 23-30;312(4):434-5. doi: 10.1001/jama.2014.7137. No abstract available.

PMID:
25038363
42.

Association of increased postoperative opioid administration with non-small-cell lung cancer recurrence: a retrospective analysis.

Maher DP, Wong W, White PF, McKenna R Jr, Rosner H, Shamloo B, Louy C, Wender R, Yumul R, Zhang V.

Br J Anaesth. 2014 Jul;113 Suppl 1:i88-94. doi: 10.1093/bja/aeu192. Epub 2014 Jul 9.

43.

An update on breast cancer screening and prevention.

de la Cruz MS, Sarfaty M, Wender RC.

Prim Care. 2014 Jun;41(2):283-306. doi: 10.1016/j.pop.2014.02.006. Epub 2014 Mar 27. Review.

PMID:
24830609
44.

Evolution of "the guideline advantage": lessons learned from the front lines of outpatient performance measurement.

Bufalino V, Bauman MA, Shubrook JH, Balch AJ, Boone C, Vennum K, Bradley S, Wender RC, Minners R, Arnett D; American Cancer Society; American Diabetes Association; American Heart Association.

Diabetes Care. 2014 Jun;37(6):1745-50. doi: 10.2337/dc14-0901. Epub 2014 Apr 30. Review. No abstract available.

PMID:
24789936
45.

Evolution of "The Guideline Advantage": Lessons learned from the front lines of outpatient performance measurement.

Bufalino V, Bauman MA, Shubrook JH, Balch AJ, Boone C, Vennum K, Bradley S, Wender RC, Minners R, Arnett D; American Cancer Society, American Diabetes Association, and American Heart Association.

CA Cancer J Clin. 2014 May-Jun;64(3):157-63. doi: 10.3322/caac.21233. Epub 2014 Apr 30. No abstract available.

46.

Evolution of "the guideline advantage": lessons learned from the front lines of outpatient performance measurement.

Bufalino V, Bauman MA, Shubrook JH, Balch AJ, Boone C, Vennum K, Bradley S, Wender RC, Minners R, Arnett D; American Cancer Society; American Diabetes Association; American Heart Association.

Circ Cardiovasc Qual Outcomes. 2014 May;7(3):493-8. doi: 10.1161/HCQ.0000000000000003. Epub 2014 Apr 30. Review. No abstract available.

PMID:
24785960
47.

Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening.

Smith RA, Manassaram-Baptiste D, Brooks D, Cokkinides V, Doroshenk M, Saslow D, Wender RC, Brawley OW.

CA Cancer J Clin. 2014 Jan-Feb;64(1):30-51. doi: 10.3322/caac.21212. Epub 2014 Jan 9. Review.

48.

The first Surgeon General's report on smoking and health: the 50th anniversary.

Brawley OW, Glynn TJ, Khuri FR, Wender RC, Seffrin JR.

CA Cancer J Clin. 2014 Jan-Feb;64(1):5-8. doi: 10.3322/caac.21210. Epub 2013 Nov 18. No abstract available.

49.

Caring for cancer survivors: time for action, but let's talk first.

Wender RC.

Fam Med. 2013 Jul-Aug;45(7):461-2. No abstract available.

50.

ADFM's 2013 winter meeting focus: moving to value-based health care.

Perkins A, Miller H, Davis A, Thompson B, Campbell T, James P, Bassford T, Borkan J, David A, Ewigman B, Kuzel A, Magill M, Matson C, Newton W, Wender R.

Ann Fam Med. 2013 Jul-Aug;11(4):383-4. doi: 10.1370/afm.1557. No abstract available.

Supplemental Content

Loading ...
Support Center